Table 1.
Gene and Localization | Resistance to | Mode of Action | Level of Evidence | References |
Plasma membrane | ||||
MDR1* (P-glycoprotein 1) | Anthracyclines, vinca alkaloids, taxoids, etoposide | Efflux of drugs | Human xenotransplant model (human clinical trial)† | [17,74] |
Multidrug resistance-related protein‡ | Anthracyclines, vinca alkaloids, taxoids, etoposide | Efflux of drugs | Murine in vivo model | [75] |
hENT2 nucleoside transporter | Trimetrexate, tomudex (plus NBMPR§) | Nucleoside transporter | Murine in vivo model | [76] |
ABLG2¶ | Anthracyclines, taxoids | Efflux of drugs (side population) | Human cell lines | [77] |
Cytoplasmic | ||||
DHFR | Methotrexate, trimetrexate | Mutant form is unaffected by the drug | Large animal model | [78] |
CDD | ara-C, gemcitabine | Detoxification of prodrug | Murine in vivo model | [39] |
Aldehyde dehydrogenase | Cyclophosphamide | Detoxification of prodrug | Murine in vivo model | [79] |
Glutathione S-transferase | Cyclophosphamide, anthracyclines | Detoxification of prodrug | Murine in vivo model | [80] |
Thymidylate synthase | 5-Fluorouracil, tomudex | Mutant form is unaffected by the drug | Murine primary cells | [81] |
Ribonucleotide reductase | Hydroxyurea | Mutant form is unaffected by the drug | Murine in vivo model | [82,83] |
Nuclear | ||||
MGMT# | Chloroethylnitrosoureas and decarbazine derivatives (plus BG) | Removal of O6 adducts from the DNA | Human clinical trial | [11] |
APN1(yeast)/APE(human)** | Bleomycin and ionizing radiation | Repairs AP sites, oxidative damage, and alkylation damage in DNA | Human cell lines | [84,85] |
8-Oxoguanine glycosylase/Fapy-DNA glycosylase | ThioTEPA | Removal of alkylated bases in DNA | Murine primary cells/murine in vivo model | [86] |
Superoxide dismutase | Anthracyclines and paraquat | Protection against oxidative damage | Human cell lines | [75,87] |
Topoisomerase I | Camptothecin | DNA repair function | Human cell lines | [78] |
Topoisomerase II | Anthracyclines and etoposide | DNA repair function | Human cell lines | [79] |
HPRT†† | 6-Thioguanine | Ribosylation of purine analogs | Murine in vivo model | [88] |
Multidrug resistance gene.
Failed due to technical problems.
Multidrug resistance-related protein coding gene.
Nitrobenzylmercaptopurine riboside.
ATP-binding cassette subfamily G member 2 (also known as breast cancer resistance protein).
O6-Methylguanine DNA-methyltransferase.
Apurinic/apyrimidinic endonuclease.
Hypoxanthine-guanine phosphoribosyl transferase.